TMCI
Treace Medical Concepts, Inc.
NasdaqGSUSDEQUITY
DELAYED
Last price
4.40
▼ 0.06 (1.35%)
MARKET · —
Price
Open
4.20
Prev close
4.46
Day high
4.54
Day low
4.28
Volume
252.76K
Market cap
—
P/E (TTM)
—
52W range
1.17 – 7.78
Trailing performance
Returnvs SPY
1W
-9.39%
-8.0%
1M
+7.16%
+3.4%
3M
+52.82%
+49.7%
6M
+129.63%
+118.6%
YTD
+77.14%
+64.9%
1Y
-39.22%
-59.2%
3Y
-74.27%
-148.4%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
4.58
-3.87% from price
SMA 20
4.50
-3.48% from price
SMA 50
4.34
-0.11% from price
SMA 100
3.35
+31.35% from price
SMA 200
2.89
+49.95% from price
EMA 12
4.51
-2.48% from price
EMA 26
4.44
-0.91% from price
EMA 50
4.18
+5.29% from price
RSI (14)
47.7
Neutral
MACD (12,26,9)
0.07
Hist -0.04
ATR (14)
0.36
8.41% of price
Realised vol 30D
66.2%
Annualised
Bollinger upper
4.99
20, 2σ
Bollinger lower
4.01
20, 2σ
50 / 200 cross
Golden
4.34 vs 2.89
Trend bias
Above 200
+49.95%
Risk profile
Beta vs SPY
1.62
More volatile than market
Correlation to SPY
0.24
Largely independent
Realised vol 30D
66.2%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-84.4%
Peak to trough
Max drawdown 5Y
-96.0%
Peak to trough
ATR 14
0.36
8.41% of price
Beta (reported)
—
5Y monthly, from filing
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
Treace Medical (TMCI) Q2 2026 Earnings Call Transcript
Motley Fool · 8d ago
Truist Securities Adjusts PT on Treace Medical Concepts to $5 From $4, Keeps Hold Rating
MT Newswires · 12d ago
Treace Medical Concepts, Inc. Q2 2026 Earnings Call Summary
Moby · 15d ago
Treace Medical Concepts Inc (TMCI) (Q2 2026) Earnings Call Highlights: Revenue Declines 4% but ...
GuruFocus.com · 15d ago
Treace Medical Concepts Q2 Earnings Call Highlights
MarketBeat · 15d ago
Treace Medical Concepts (TMCI) Reports Q2 Loss, Tops Revenue Estimates
Zacks · 15d ago
Treace Medical Concepts: Q2 Earnings Snapshot
Associated Press · 15d ago
Treace Medical Concepts Reports Second Quarter 2026 Financial Results
GlobeNewswire · 15d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.